Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cox

Showing results (1251-1260 of 1,340) with videos related to

Pageof 134
Sort By:
Scientific Reports|September 26, 2023
PET imaging of microglia using PBR28suv determines therapeutic efficacy of autologous bone marrow mononuclear cells therapy in traumatic brain injurySupinder S Bedi, Michael C Scott, Max A Skibber, et al.
Plos One|December 9, 2022
A quality improvement study on the relationship between intranasal povidone-iodine and anesthesia and the nasal microbiota of surgery patientsEric N Hammond, Ashley E Kates, Nathan Putman-Buehler, et al.
AIDS Research and Human Retroviruses|December 7, 2006
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjectsTimothy W Tobery, Sheri A Dubey, Kiersten Anderson, et al.
Stroke|June 15, 2019
Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell DiseaseEdward N Kija, Dawn E Saunders, Emmanuel Munubhi, et al.
Scientific Reports|July 3, 2020
Injury intensifies T cell mediated graft-versus-host disease in a humanized model of traumatic brain injuryMiguel F Diaz, Paulina D Horton, Akshita Kumar, et al.
BMC Infectious Diseases|December 5, 2018
Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell responseZhifeng Chen, Kara S Cox, Aimin Tang, et al.
Antiviral Research|August 1, 1997
SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2R Albin, R Chase, C Risano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2013
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumoursJeffrey R Infante, Kyriakos P Papadopoulos, Johanna C Bendell, et al.
Stem Cells (Dayton, Ohio)|August 25, 2015
TIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain InjuryStuart L Gibb, Yuhai Zhao, Daniel Potter, et al.
Virology|September 17, 2008
The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infectionLeslie L Chavez, Miles P Davenport, John W Shiver, et al.
Pageof 134

Showing results (1251-1260 of 1,340) with videos related to

Sort By:
Pageof 134
Scientific Reports|September 26, 2023
PET imaging of microglia using PBR28suv determines therapeutic efficacy of autologous bone marrow mononuclear cells therapy in traumatic brain injurySupinder S Bedi, Michael C Scott, Max A Skibber, et al.
Plos One|December 9, 2022
A quality improvement study on the relationship between intranasal povidone-iodine and anesthesia and the nasal microbiota of surgery patientsEric N Hammond, Ashley E Kates, Nathan Putman-Buehler, et al.
AIDS Research and Human Retroviruses|December 7, 2006
A comparison of standard immunogenicity assays for monitoring HIV type 1 gag-specific T cell responses in Ad5 HIV Type 1 gag vaccinated human subjectsTimothy W Tobery, Sheri A Dubey, Kiersten Anderson, et al.
Stroke|June 15, 2019
Transcranial Doppler and Magnetic Resonance in Tanzanian Children With Sickle Cell DiseaseEdward N Kija, Dawn E Saunders, Emmanuel Munubhi, et al.
Scientific Reports|July 3, 2020
Injury intensifies T cell mediated graft-versus-host disease in a humanized model of traumatic brain injuryMiguel F Diaz, Paulina D Horton, Akshita Kumar, et al.
BMC Infectious Diseases|December 5, 2018
Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell responseZhifeng Chen, Kara S Cox, Aimin Tang, et al.
Antiviral Research|August 1, 1997
SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2R Albin, R Chase, C Risano, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2013
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumoursJeffrey R Infante, Kyriakos P Papadopoulos, Johanna C Bendell, et al.
Stem Cells (Dayton, Ohio)|August 25, 2015
TIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain InjuryStuart L Gibb, Yuhai Zhao, Daniel Potter, et al.
Virology|September 17, 2008
The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infectionLeslie L Chavez, Miles P Davenport, John W Shiver, et al.
Pageof 134